ACCESS Newswire
06 Sep 2019, 14:49 GMT+10
HAMBURG, GERMANY / ACCESSWIRE / September 6, 2019 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that its management will be presenting at and attending the following upcoming conferences:
J.P. Morgan Cazenove Pan-European Small/Mid Cap Conference, London, UK
- Date: Wednesday, 11 September 2019
- Venue: London, UK
- Attendee: Enno Spillner, Chief Financial Officer
Bank of America Merrill Lynch Global Healthcare Conference 2019, London, UK
- Date: Wednesday, 18 September 2019,
Presentation: 18 September 2019, 4.25 pm BST
- Venue: London, UK
- Attendee: Werner Lanthaler, Chief Executive Officer
Baader Investment Conference, Munich, Germany
- Date: Monday, 23 September 2019,
Presentation: 23 September 2019, 5.15 pm CEST
- Venue: Munich, Germany
- Attendee: Enno Spillner, Chief Financial Officer
Berenberg and Goldman Sachs Eighth German Corporate Conference, Munich, Germany
- Date: Tuesday, 24 September 2019,
Presentation: 24 September 2019, 2.30 pm CEST
- Venue: Munich, Germany
- Attendee: Enno Spillner, Chief Financial Officer
Ladenburg Thalmann Healthcare Conference, New York, NY, USA
- Date: Tuesday, 24 September 2019,
Presentation: 24 September 2019, 10.30 am EDT
- Venue: New York, NY, USA
- Attendee: Dr Werner Lanthaler, Chief Executive Officer
2019 Cantor Global Healthcare Conference, New York, NY, USA
- Date: Wednesday, 02 October 2019,
Presentation: 02 October 2019, 3.00 pm EDT
- Venue: New York, NY, USA
- Attendee: Dr Werner Lanthaler, Chief Executive Officer
ABOUT EVOTEC SE
Evotec is a drug discovery alliance and development partnership company focused on rapidly progressing innovative product approaches with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists. We operate worldwide and our more than 2,800 employees provide the highest quality stand-alone and integrated drug discovery and development solutions. We cover all activities from target-to-clinic to meet the industry's need for innovation and efficiency in drug discovery and development (EVT Execute). The Company has established a unique position by assembling top-class scientific experts and integrating state-of-the-art technologies as well as substantial experience and expertise in key therapeutic areas including neuronal diseases, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. On this basis, Evotec has built a broad and deep pipeline of approx. 100 co-owned product opportunities at clinical, pre-clinical and discovery stages (EVT Innovate). Evotec has established multiple long-term alliances with partners including Bayer, Boehringer Ingelheim, Celgene, CHDI, Novartis, Novo Nordisk, Pfizer, Sanofi, Takeda, UCB and others. For additional information please go to www.evotec.com and follow us on Twitter @Evotec.
FORWARD LOOKING STATEMENTS
Information set forth in this press release contains forward-looking statements, which involve a number of risks and uncertainties. The forward-looking statements contained herein represent the judgement of Evotec as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond our control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any such statements to reflect any change in our expectations or any change in events, conditions or circumstances on which any such statement is based.
Contact Evotec SE:
Gabriele Hansen, VP Corporate Communications, Marketing & Investor Relations, Phone: +49.(0)40.56081-255, [email protected]
SOURCE: Evotec AG
Get a daily dose of Pittsburgh Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Pittsburgh Star.
More InformationFRANKLIN, Tennessee: Hundreds of thousands of Nissan and Infiniti vehicles are being recalled across the United States due to a potential...
(Photo credit: Eric Hartline-Imagn Images) Zack Wheeler threw a dazzling one-hitter with 12 strikeouts as the Philadelphia Phillies...
(Photo credit: David Banks-Imagn Images) The Chicago Cubs have been beset by pitching injuries this season, with Jameson Taillon...
(Photo credit: Ron Chenoy-Imagn Images) The Chicago White Sox didn't win their 31st game of 2024 until Aug. 21 en route to setting...
(Photo credit: Bob DeChiara-Imagn Images) As the No. 2 overall pick in the 2024 draft, Cincinnati Reds right-hander Chase Burns certainly...
(Photo credit: John E. Sokolowski-Imagn Images) Addison Barger hit an RBI single with two outs in the 11th inning and the Toronto...
MOSCOW, Russia: This week, Russia became the first country to officially recognize the Taliban as the government of Afghanistan since...
CAIRO, Egypt: This week, both Hamas and Israel shared their views ahead of expected peace talks about a new U.S.-backed ceasefire plan....
WASHINGTON, D.C.: The Trump administration has made public a visa decision that would usually be kept private. It did this to send...
MADRID, Spain: Liverpool footballer Diogo Jota and his younger brother, André Silva, have died in a car accident in Spain. Spanish...
LONDON, U.K.: An unrelenting heatwave sweeping across Europe has pushed early summer temperatures to historic highs, triggering deadly...
President Donald Trump's plans to build a space-based Golden Dome missile defense shield have drawn immediate criticism from China,...